Regency Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,959
Closed -$793K 55
2023
Q3
$793K Buy
+3,959
New +$787K 0.67% 28
2022
Q2
Sell
-11,181
Closed -$2.66M 92
2022
Q1
$2.66M Sell
11,181
-614
-5% -$144K 1.93% 21
2021
Q4
$2.69M Buy
11,795
+616
+6% +$136K 1.71% 20
2021
Q3
$2.16M Buy
11,179
+4,836
+76% +$980K 1.52% 21
2021
Q2
$1.35M Buy
6,343
+4,176
+193% +$882K 1.02% 38
2021
Q1
$443K Buy
+2,167
New +$427K 0.47% 57

Other funds holding CME

Regency Capital Management's CME Position: Q4 2023 in Review

Regency Capital Management sold out of CME Group (CME) in Q4 2023, closing a stake of 3,959 shares — an estimated $793K sold.

Regency Capital Management first reported a position in CME in Q1 2021 and held it in 6 quarters. The position peaked at $2.69M in Q4 2021. 1,361 funds tracked by Wall St. Rank hold CME as of Q4 2023.

  • Regency Capital Management reported no remaining CME Group position as of Q4 2023 after selling out during the quarter.
  • Regency Capital Management sold 3,959 CME Group shares in Q4 2023, an estimated $793K.
  • Regency Capital Management first reported a position in CME Group in Q1 2021 and held it in 6 quarters.
  • Regency Capital Management's CME Group position peaked at $2.69M in Q4 2021.
  • 1,361 funds tracked by Wall St. Rank held CME Group as of Q4 2023.

Based on Regency Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.